InsidersTradesSigma
Follow the 华兰疫苗 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 华兰疫苗 has recorded 1 insider filings. Market capitalisation: €10.4bn. The latest transaction was disclosed on 14 July 2022 (Purchase). Among the most active insiders: 娄源成. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华兰疫苗 is a company focused on the research, development, and production of vaccines. It primarily operates in the Chinese market and concentrates on public health solutions.